News Focus
News Focus
icon url

Investor2014

10/20/22 8:21 AM

#379056 RE: tradeherpete #379053

I didn't go back on my previous statement, but I am not sure I posed it as a prediction or encouraged anyone to expect such a thing.
icon url

tredenwater2

10/20/22 9:36 AM

#379093 RE: tradeherpete #379053

So trader how would they phrase someone who actually improved in the trial with the endpoint “reduction in cognitive decline”. Perhaps “negative” reduction?

I see a new measuring “scale” being designed/implemented along side this trial. Lol
icon url

McMagyar

10/20/22 9:50 AM

#379099 RE: tradeherpete #379053

Improvement from baseline
No Reduction

100% of High Dosage 50mg

For 150 Trial participants

150 participants very little reduction in score..

150 patients. Typical 4 point drop over 48 weeks